EPCAM and prostate cancer: However, current often epithelial cell adhesion molecule (EpCAM)-based detection methods, commonly used on peripheral blood (PB) samples, are limited to a few cancers with higher CTC numbers such as breast and prostate cancer, or very rare cases of patients with exceptionally high CTC numbers.